ID   FORE
AC   CVCL_E667
SY   FORE-9317; TER330
DR   dbMHC; 48862
DR   ECACC; 94050305
DR   IHW; IHW09317
DR   IPD-IMGT/HLA; 10587
DR   Wikidata; Q54835110
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian; French.
CC   HLA typing: A*02:01:01:01,24:02:01:01; B*51:01:01,15:01:01:01; C*14:02:01,03:03:01; DPA1*01:03:01:03; DPB1*03:01:01,06:01; DQA1*03:01:01,01:02:02; DQB1*03:02:01,05:02:01; DRB1*04:04:01,16:04; DRB4*01:03:01:03; DRB5*02:02; DRB6*02:02 (IPD-IMGT/HLA=10587).
CC   HLA typing: A*02:01:01:01,24:02:01:01; B*51:01:01:01,15:01:01:01; C*14:02:01:01,03:03:01:01; DPA1*01:03:01:03; DPB1*03:01:01,06:01:01; DQA1*01:02:02,03:01:01; DQB1*03:02:01,05:02:01; DRB1*04:04:01,16:04; DRB4*01:03:01; DRB5*02:02 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
RX   PubMed=30844424; DOI=10.1016/j.humimm.2019.03.001;
RA   Creary L.E., Guerra S.G., Chong W., Brown C.J., Turner T.R.,
RA   Robinson J., Bultitude W.P., Mayor N.P., Marsh S.G.E., Saito K.,
RA   Lam K., Duke J.L., Mosbruger T.L., Ferriola D., Monos D.S., Willis A.,
RA   Askar M., Fischer G.F., Saw C.L., Ragoussis J., Petrek M.,
RA   Serra-Pages C., Juan Otero M., Stavropoulos-Giokas C., Dinou A., Ameen R.,
RA   Al Shemmari S., Spierings E., Gendzekhadze K., Morris G.P., Zhang Q.-H.,
RA   Kashi Z., Hsu S., Gangavarapu S., Mallempati K.C., Yamamoto F.,
RA   Osoegawa K., Vayntrub T., Chang C.-J., Hansen J.A.,
RA   Fernandez-Vina M.A.;
RT   "Next-generation HLA typing of 382 International Histocompatibility
RT   Working Group reference B-lymphoblastoid cell lines: report from the
RT   17th International HLA and Immunogenetics Workshop.";
RL   Hum. Immunol. 80:449-460(2019).
//